Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianling Liu

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|January 27, 2022
The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to CisplatinShasha He, Yeqian Feng, Wen Zou, et al.
The Journal of Biological Chemistry|October 29, 2010
Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-LAnping Wang, Meilian Liu, Xianling Liu, et al.
Frontiers in Oncology|June 21, 2021
Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint InhibitorsTao Hou, Shun Jiang, Yapeng Wang, et al.
Cancer Management and Research|February 26, 2021
Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIsShun Jiang, Sisi Wang, Qianqian Wang, et al.
Clinical and Experimental Pharmacology & Physiology|September 27, 2022
Dapagliflozin modulates the faecal microbiota after myocardial infarction in non-diabetic miceZhongming Li, Kai Wang, Yinzhang Ding, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 30, 2025
Enzyme-powered micellar nanoreactors enable tumor-specific, cascade-amplified prodrug activation for synergistic oxidation-chemo-immunotherapyXin Li, Lili Sun, Xianling Liu, et al.
Frontiers in Immunology|June 7, 2023
Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancerChao Xu, Wen Zou, Lei Zhang, et al.
Frontiers in Oncology|January 7, 2021
Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint InhibitorsTao Hou, Shun Jiang, Yapeng Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2020
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataMin Lu, Chunhong Hu, Fang Wu, et al.
Journal of Biomedical Research|December 3, 2021
Construction of miRNA-mRNA network reveals crucial miRNAs and genes in acute myocardial infarctionKai Wang, Zhongming Li, Wenjie Ma, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|January 27, 2022
The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to CisplatinShasha He, Yeqian Feng, Wen Zou, et al.
The Journal of Biological Chemistry|October 29, 2010
Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-LAnping Wang, Meilian Liu, Xianling Liu, et al.
Frontiers in Oncology|June 21, 2021
Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint InhibitorsTao Hou, Shun Jiang, Yapeng Wang, et al.
Cancer Management and Research|February 26, 2021
Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIsShun Jiang, Sisi Wang, Qianqian Wang, et al.
Clinical and Experimental Pharmacology & Physiology|September 27, 2022
Dapagliflozin modulates the faecal microbiota after myocardial infarction in non-diabetic miceZhongming Li, Kai Wang, Yinzhang Ding, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 30, 2025
Enzyme-powered micellar nanoreactors enable tumor-specific, cascade-amplified prodrug activation for synergistic oxidation-chemo-immunotherapyXin Li, Lili Sun, Xianling Liu, et al.
Frontiers in Immunology|June 7, 2023
Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancerChao Xu, Wen Zou, Lei Zhang, et al.
Frontiers in Oncology|January 7, 2021
Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint InhibitorsTao Hou, Shun Jiang, Yapeng Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2020
MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataMin Lu, Chunhong Hu, Fang Wu, et al.
Journal of Biomedical Research|December 3, 2021
Construction of miRNA-mRNA network reveals crucial miRNAs and genes in acute myocardial infarctionKai Wang, Zhongming Li, Wenjie Ma, et al.
Pageof 12